Selective progesterone receptor modulator: Difference between revisions

Selective progesterone receptor modulator
	File:Ulipristal acetate skeletal.svg
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

Latest revision as of 02:43, 11 December 2024

Overview of selective progesterone receptor modulators

File:Protein PGR PDB 1a28.png

Structure of the progesterone receptor (PGR) bound to a ligand.

A selective progesterone receptor modulator (SPRM) is a type of drug that acts on the progesterone receptor (PR) in a tissue-selective manner. SPRMs can have varying effects in different tissues, acting as agonists in some and antagonists in others. This unique property makes them useful in a variety of clinical applications, particularly in the fields of gynecology and reproductive health.

Mechanism of Action[edit]

File:Nuclear receptor action.png

Mechanism of nuclear receptor action.

SPRM drugs bind to the progesterone receptor, which is a type of nuclear receptor. Upon binding, they can modulate the receptor's activity, leading to changes in gene expression. The selective nature of SPRMs means that they can either activate or inhibit the receptor depending on the tissue type. This selectivity is due to differences in co-regulator proteins and receptor isoforms present in different tissues.

Clinical Uses[edit]

SPRM drugs are primarily used in the treatment of conditions such as uterine fibroids, endometriosis, and as emergency contraceptives. One of the most well-known SPRMs is ulipristal acetate, which is used for emergency contraception and the treatment of uterine fibroids.

Uterine Fibroids[edit]

SPRM drugs can reduce the size of uterine fibroids and alleviate symptoms such as heavy menstrual bleeding. They work by modulating the progesterone receptor in the uterine tissue, which is crucial for fibroid growth.

Emergency Contraception[edit]

Ulipristal acetate is used as an emergency contraceptive. It works by delaying ovulation and altering the endometrium, making it less suitable for implantation.

Research and Development[edit]

Research is ongoing to develop new SPRMs with improved selectivity and fewer side effects. The structure-activity relationship (SAR) of SPRMs is a key area of study, as it helps in understanding how different chemical modifications can affect the drug's selectivity and efficacy.

File:SAR of Mifepristone analogs.png

Structure-activity relationship of mifepristone analogs.

Side Effects[edit]

Common side effects of SPRMs include headache, nausea, and abdominal pain. Long-term use can lead to changes in the endometrium, which requires monitoring.

Also see[edit]

Template:Reproductive system drugs

@@ Line 1: / Line 1: @@
-==Selective Progesterone Receptor Modulator==
+{{Short description|Overview of selective progesterone receptor modulators}}
+{{Drugbox
+| Verifiedfields = changed
+| verifiedrevid = 477002679
+| IUPAC_name = (2E)-1-(4-(4-(dimethylamino)phenyl)-3-oxo-3,4-dihydroquinoxalin-2(1H)-ylidene)-3-(4-hydroxyphenyl)prop-2-en-1-one
+| image = Ulipristal acetate skeletal.svg
+| width = 200
+}}
-A selective progesterone receptor modulator (SPRM) is a type of medication that selectively targets and modulates the activity of progesterone receptors in the body. These receptors play a crucial role in various physiological processes, including reproductive function, hormone regulation, and the development of certain diseases. By selectively targeting progesterone receptors, SPRMs can have a wide range of therapeutic applications.
+[[File:Protein PGR PDB 1a28.png|thumb|Structure of the progesterone receptor (PGR) bound to a ligand.]]
-===Mechanism of Action===
+A '''selective progesterone receptor modulator''' (SPRM) is a type of drug that acts on the [[progesterone receptor]] (PR) in a tissue-selective manner. SPRMs can have varying effects in different tissues, acting as agonists in some and antagonists in others. This unique property makes them useful in a variety of clinical applications, particularly in the fields of [[gynecology]] and [[reproductive health]].
-SPRMs work by binding to progesterone receptors and modulating their activity. Progesterone receptors are found in various tissues throughout the body, including the uterus, ovaries, breast, and brain. They are involved in regulating the menstrual cycle, maintaining pregnancy, and influencing the growth and development of certain cancers.
+==Mechanism of Action==
+[[File:Nuclear receptor action.png|thumb|Mechanism of nuclear receptor action.]]
+SPRM drugs bind to the progesterone receptor, which is a type of [[nuclear receptor]]. Upon binding, they can modulate the receptor's activity, leading to changes in gene expression. The selective nature of SPRMs means that they can either activate or inhibit the receptor depending on the tissue type. This selectivity is due to differences in co-regulator proteins and receptor isoforms present in different tissues.
-When an SPRM binds to a progesterone receptor, it can have different effects depending on the specific receptor and tissue involved. In some cases, SPRMs can act as agonists, activating the receptor and mimicking the effects of progesterone. In other cases, they can act as antagonists, blocking the receptor and inhibiting the effects of progesterone.
+==Clinical Uses==
+SPRM drugs are primarily used in the treatment of conditions such as [[uterine fibroids]], [[endometriosis]], and as emergency contraceptives. One of the most well-known SPRMs is [[ulipristal acetate]], which is used for emergency contraception and the treatment of uterine fibroids.
-===Therapeutic Applications===
+===Uterine Fibroids===
+SPRM drugs can reduce the size of uterine fibroids and alleviate symptoms such as heavy menstrual bleeding. They work by modulating the progesterone receptor in the uterine tissue, which is crucial for fibroid growth.
-SPRMs have a wide range of therapeutic applications due to their ability to selectively modulate progesterone receptors. Some of the key therapeutic areas where SPRMs are used include:
+===Emergency Contraception===
+Ulipristal acetate is used as an emergency contraceptive. It works by delaying ovulation and altering the endometrium, making it less suitable for implantation.
-====Contraception====
+==Research and Development==
+Research is ongoing to develop new SPRMs with improved selectivity and fewer side effects. The structure-activity relationship (SAR) of SPRMs is a key area of study, as it helps in understanding how different chemical modifications can affect the drug's selectivity and efficacy.
-SPRMs can be used as a form of contraception by inhibiting ovulation and altering the uterine lining, making it less receptive to implantation. One example of an SPRM used for contraception is ulipristal acetate, which is available as an emergency contraceptive pill.
+[[File:SAR of Mifepristone analogs.png|thumb|Structure-activity relationship of mifepristone analogs.]]
-====Menstrual Disorders====
+==Side Effects==
+Common side effects of SPRMs include headache, nausea, and abdominal pain. Long-term use can lead to changes in the endometrium, which requires monitoring.
-SPRMs can be used to treat various menstrual disorders, such as heavy menstrual bleeding and uterine fibroids. By modulating progesterone receptors in the uterus, SPRMs can help regulate the menstrual cycle and reduce excessive bleeding. Mifepristone is an example of an SPRM used for this purpose.
+==Also see==
+* [[Progesterone receptor]]
+* [[Ulipristal acetate]]
+* [[Mifepristone]]
+* [[Nuclear receptor]]
-====Endometriosis====
+{{Reproductive system drugs}}
+{{Contraception}}
-Endometriosis is a condition where the tissue that normally lines the uterus grows outside of it, causing pain and other symptoms. SPRMs can be used to treat endometriosis by inhibiting the growth of endometrial tissue and reducing inflammation. Examples of SPRMs used for endometriosis include ulipristal acetate and mifepristone.
+[[Category:Selective progesterone receptor modulators]]
+[[Category:Reproductive health drugs]]
-====Breast Cancer====
-SPRMs can also be used in the treatment of certain types of breast cancer. By blocking progesterone receptors in breast cancer cells, SPRMs can inhibit the growth and spread of tumors. Mifepristone is an example of an SPRM used in the treatment of breast cancer.
-===Safety and Side Effects===
-Like any medication, SPRMs can have potential side effects. Common side effects include nausea, headache, dizziness, and changes in menstrual bleeding patterns. In rare cases, SPRMs can also cause more serious side effects, such as liver damage or allergic reactions. It is important to consult a healthcare professional before starting any SPRM treatment to discuss potential risks and benefits.
-===Conclusion===
-Selective progesterone receptor modulators are a class of medications that selectively target and modulate progesterone receptors in the body. They have a wide range of therapeutic applications, including contraception, treatment of menstrual disorders, endometriosis, and breast cancer. While SPRMs can be effective in treating these conditions, it is important to use them under the guidance of a healthcare professional to ensure safety and minimize potential side effects.<br>{{stub}}
-{{dictionary-stub1}}